Loading clinical trials...
Loading clinical trials...
Integrated Treatment of Hepatitis C Virus Infection Among Patients With Injecting Drug Abuse:a Randomised Controlled Trial (INTRO-HCV)
Conditions
Interventions
Health care delivery
Locations
2
Norway
Department of Addiction Medicine, Haukeland University Hospital
Bergen, Hordaland, Norway
LAR Helse Stavanger HF
Stavanger, Rogaland, Norway
Start Date
May 18, 2017
Primary Completion Date
March 15, 2020
Completion Date
March 8, 2025
Last Updated
September 16, 2025
NCT05870969
NCT03200379
NCT03987503
NCT05397067
NCT04382404
NCT01849562
Lead Sponsor
Haukeland University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions